TrialJournal for immunotherapy of cancer2026
Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in patients with metastatic NSCLC: the phase II RECLAIM trial.
Ezgi B Ulas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.